These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 15853912)
21. Dose-dependent improvements in outcome with adenoviral expression of interleukin-10 in a murine model of multisystem organ failure. McAuliffe PF; Murday ME; Efron PA; Scumpia PO; Ungaro R; Abouhamze A; Tannahill CL; Hutchins B; LaFace D; Moldawer LL Gene Ther; 2006 Feb; 13(3):276-82. PubMed ID: 16251998 [TBL] [Abstract][Full Text] [Related]
22. In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus. Chen L; Liang GP; Tang XD; Chen T; Cai YG; Fang DC; Yu ST; Luo YH; Yang SM Biochem Biophys Res Commun; 2006 Dec; 351(4):927-34. PubMed ID: 17097054 [TBL] [Abstract][Full Text] [Related]
23. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma. Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245 [TBL] [Abstract][Full Text] [Related]
24. Factors involved in the maturation of murine dendritic cells transduced with adenoviral vector variants. Kanagawa N; Koretomo R; Murakami S; Sakurai F; Mizuguchi H; Nakagawa S; Fujita T; Yamamoto A; Okada N Virology; 2008 May; 374(2):411-20. PubMed ID: 18272197 [TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of intrinsic immunogenicity of reporter and insulin gene therapy plasmids. Ratanamart J; Huggins CG; Kirby JA; Shaw JA J Gene Med; 2007 Aug; 9(8):703-14. PubMed ID: 17595049 [TBL] [Abstract][Full Text] [Related]
26. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis]. Pan JP; Weng YS; Wu QQ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366 [TBL] [Abstract][Full Text] [Related]
27. Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors. Dullaers M; Van Meirvenne S; Heirman C; Straetman L; Bonehill A; Aerts JL; Thielemans K; Breckpot K Gene Ther; 2006 Apr; 13(7):630-40. PubMed ID: 16355115 [TBL] [Abstract][Full Text] [Related]
28. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication. Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004 [TBL] [Abstract][Full Text] [Related]
29. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response. Flohé SB; Agrawal H; Schmitz D; Gertz M; Flohé S; Schade FU J Leukoc Biol; 2006 Mar; 79(3):473-81. PubMed ID: 16365154 [TBL] [Abstract][Full Text] [Related]
30. Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector. van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Agervig Tarp M; Mandel U; Clausen H; Havenga MJ; Duffour MT; García-Vallejo JJ; Germeraad WT; Bos GM Cytotherapy; 2006; 8(1):24-35. PubMed ID: 16627342 [TBL] [Abstract][Full Text] [Related]
31. Murine dendritic cells generated under serum-free conditions have a mature phenotype and efficiently induce primary immune responses. Warncke M; Dodero A; Dierbach H; Follo M; Veelken H J Immunol Methods; 2006 Mar; 310(1-2):1-11. PubMed ID: 16337648 [TBL] [Abstract][Full Text] [Related]
32. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. den Brok MH; Sutmuller RP; Nierkens S; Bennink EJ; Frielink C; Toonen LW; Boerman OC; Figdor CG; Ruers TJ; Adema GJ Br J Cancer; 2006 Oct; 95(7):896-905. PubMed ID: 16953240 [TBL] [Abstract][Full Text] [Related]
33. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy. Dullaers M; Thielemans K J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the vector systems for gene transduction into rat dendritic cells and peritoneal exudate cells. Satoh E; Hara Y; Fuji N; Li XK; Teramoto K; Arii S; Kimura H Transplant Proc; 2005 May; 37(4):1953-6. PubMed ID: 15919516 [TBL] [Abstract][Full Text] [Related]
35. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gong J; Chen L; Chen D; Kashiwaba M; Manome Y; Tanaka T; Kufe D Gene Ther; 1997 Oct; 4(10):1023-8. PubMed ID: 9415307 [TBL] [Abstract][Full Text] [Related]
36. Intramuscular immunization with plasmid coexpressing tumour antigen and Flt-3L results in potent tumour regression. Fong CL; Mok CL; Hui KM Gene Ther; 2006 Feb; 13(3):245-56. PubMed ID: 16163376 [TBL] [Abstract][Full Text] [Related]
37. [Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide]. Tan XH; Liu C; Wan YH Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):658-61. PubMed ID: 17274369 [TBL] [Abstract][Full Text] [Related]
38. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Yang SC; Batra RK; Hillinger S; Reckamp KL; Strieter RM; Dubinett SM; Sharma S Cancer Res; 2006 Mar; 66(6):3205-13. PubMed ID: 16540672 [TBL] [Abstract][Full Text] [Related]
39. Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity. Mukhopadhaya A; Mendecki J; Dong X; Liu L; Kalnicki S; Garg M; Alfieri A; Guha C Cancer Res; 2007 Aug; 67(16):7798-806. PubMed ID: 17699785 [TBL] [Abstract][Full Text] [Related]